Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Research Background Retatrutide (LY3437943) engages three metabolic receptors at once: GIPR, GLP-1R, and the glucagon receptor (GCGR)
Your genetic profile determines which compound works best for you
Every month, your Found care team follows up to review how you're responding, adjust your dose if needed, and help you navigate any challenges that come up
Incretin-based drugs are a class of glucose-lowering therapies that mimic or enhance the action of natural incretin hormones, primarily GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), to improve insulin secretion, suppress glucagon release, slow gastric emptying, and support weight loss in patients with type 2 diabetes and obesity
Your Transformation Starts Here Choosing our clinic means choosing a path to lasting health
Most individuals start seeing noticeable weight loss within a few months, but the response to the medication can vary
US$ 20.76
US$ 21.51
US$ 24.81
